1. Market Research
  2. > Pharmaceutical
  3. > Pharmacy Market Trends
North America Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product ; Application ; Distribution Channel ; and Country

North America Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product ; Application ; Distribution Channel ; and Country

  • December 2020
  • 103 pages
  • ID: 6004216
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Mar 10th 2021


Table of Contents

Search Inside

The North America patient controlled injectors market is expected to reach US$ 3,236.46 million by 2027 from US$ 1,261.43 million in 2019; it is expected to grow at a CAGR of 12.6% from 2020 to 2027.
The increasing prevalence of chronic diseases and limitations on conventional drug delivery system boost the growth of the market.However, the preference of alternative drug delivery restrains the growth of the market.

Technological advancements and design development, and patient-controlled injector industries consolidation are likely to fuel the growth of the North America patient controlled injectors market during the forecast period.
Patient controlled Injectors are subcutaneous drug delivery systems that adhere to the body and administer larger volumes (more than 2 mL) of a drug over an extended period.With the use of patient-controlled injectors, dosing errors, microbial contamination risks, and needle stick injuries can be avoided that are caused during parenteral drug administration using injections.

In the last few years, the pharmaceutical industry has witnessed the introduction of several innovative interventions for the treatment of various chronic diseases.
Chronic diseases—such as blood disorder, autoimmune disorders, and various types of cancer—are the leading causes of death and disability.According to the Centers for Disease Control and Prevention (CDC), in 2019, nearly 6 in 10 people suffer from at least one chronic disease in the US.

Cardiovascular diseases (CVDs) are a significant cause of mortality owing to the hectic lifestyle.As per the CDC, 1 person dies every 36 seconds in the US from CVD.

Around 655,000 people in the US die from heart disease each year—that’s 1 in every 4 deaths.Many biologics are commercially available for the treatment, but the conventional drug delivery methods are unable to provide accurate dosage.

In this case, the use of patient controlled injector drug delivery systems plays vital role to provide targeted drug delivery and prolonged drug residence to the affected areas of the cardiovascular system. Hence, the adoption of patient controlled injectors is likely to increase.
Moreover, there is an increase in the prevalence of autoimmune diseases such as plaque psoriasis, Addison disease, celiac disease - sprue (gluten-sensitive enteropathy), dermatomyositis, Graves’ disease, Hashimoto thyroiditis, multiple sclerosis, myasthenia gravis, and pernicious anemia.Thus, rising prevalence of diseases and need for easy administration have led the manufacturers to fulfill the unmet demand for the patient controlled injectors.

Above mentioned factors are leading to a rise in demand for patient controlled injectors, thereby boosting the growth of the market.
North America is reporting continuously growing number of COVID-19 cases since its outbreak.According to Worldometer, as of November 13, 2020, the number of COVID-9 positive cases is 10,880,282 with 248,635 reported deaths in the US.

The cases are also increasing in Mexico and Canada.Several measures are being taken to contain the disease and prevent the transmission.

Patients with severe health conditions such as diabetes, immune diseases, cardiovascular, and cancer need physical distancing with others; however, delays in such chronic disease treatments are distressing. Therefore, it is restraining the North America patient controlled injectors market.
In 2019, the electronic injector segment accounted for the largest market share of the North America patient controlled injectors market.Electronic injector offers various benefits such as comfort, water resistance, flexible dosing, and automatic warming of refrigerated drug as well as it is easy to use.

These benefits accelerate the demand for electronic injector. A mechanical injector eliminates the risks of skin fitting issues and allergic skin reactions; therefore, the market for mechanical injector segment is expected to grow at a faster pace during the forecast period.
A few of the major secondary sources referred to while preparing this report on the North America patient controlled injectors market are the World Health Organization (WHO), Global Burden of Disease (GBD), Centers of Disease Control and Prevention (CDC), American Heart Association (AHA), and American Diabetes Association.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

North America Over the Counter Drugs Market - Growth, Trends, and Forecasts (2020 - 2025)

  • $ 3750
  • October 2020
  • 88 pages

The North America Over the Counter (OTC) Drugs Market is anticipated to grow with a CAGR of 2.7%, during the forecast period. The OTC drugs market is innovation-driven and relies on the advent of innovative ...

  • North America
  • OTC
  • Pharmaceutical
  • Industry analysis
  • Drug Approval
  • Over The Counter Drug Sales


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on